Bionano Genomics, Inc. — Director's Dealing 2021

Nov 23, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Bionano Genomics, Inc. (BNGO)
CIK: 0001411690
Period of Report: 2021-11-19

Reporting Person: Stewart Christopher P. (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-19	Common Stock	M	22500	$0.56	Acquired	55500	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-19	Stock Option (Right to Buy)	$0.56	M	22500	Disposed	2030-09-01	Common Stock (22500)	Direct

Footnotes

F1: The shares vest in full on December 31, 2020, subject to Reporting Person's continuous service through December 31, 2020, subject to acceleration of vesting provided in the Employment Agreement, dated as of September 1, 2020, by and between the Issuer and the Reporting Person.